Invention Grant
- Patent Title: Use of GLP-1 compound for treatment of critically ill patients
- Patent Title (中): 使用GLP-1化合物治疗危重病人
-
Application No.: US12496910Application Date: 2009-07-02
-
Publication No.: US08088731B2Publication Date: 2012-01-03
- Inventor: Lotte Bjerre Knudsen , Johan Selmer , Kristian Tage Hansen
- Applicant: Lotte Bjerre Knudsen , Johan Selmer , Kristian Tage Hansen
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Teresa Chen
- Priority: DK200200184 20020207
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61P3/10 ; A61P7/12 ; C07K14/605
Abstract:
Use of medicament for life saving treatment of critically ill patients and method of treatment. The medicament comprises a GLP-1 compound which effectively controls the blood glucose level.
Public/Granted literature
- US20100311651A1 USE OF GLP-1 COMPOUND FOR TREATMENT OF CRITICALLY ILL PATIENTS Public/Granted day:2010-12-09
Information query
IPC分类:
